Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS (2021)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa756
PubMed Identifier: 33103722
Publication URI: http://europepmc.org/abstract/MED/33103722
Type: Journal Article/Review
Parent Publication: The Journal of Clinical Endocrinology & Metabolism
Issue: 1
ISSN: 0021-972X